During embryonic development, cells are instructed which position to occupy, they interpret these cues as differentiation programmes, and expand these patterns by growth. Sonic hedgehog (Shh) specifies positional identity in many organs; however, its role in growth is not well understood. In this study, we show that inactivation of Shh in external genitalia extends the cell cycle from 8.5 to 14.4 h, and genital growth is reduced by ∼75%. Transient Shh signalling establishes pattern in the genital tubercle; however, transcriptional levels of G1 cell cycle regulators are reduced. Consequently, G1 length is extended, leading to fewer progenitor cells entering S-phase. Cell cycle genes responded similarly to Shh inactivation in genitalia and limbs, suggesting that Shh may regulate growth by similar mechanisms in different organ systems. The finding that Shh regulates cell number by controlling the length of specific cell cycle phases identifies a novel mechanism by which Shh elaborates pattern during appendage development.
During embryonic development, cells are instructed which position to occupy, they interpret these cues as differentiation programmes, and expand these patterns by growth. Sonic hedgehog (Shh) specifies positional identity in many organs; however, its role in growth is not well understood. In this study, we show that inactivation of Shh in external genitalia extends the cell cycle from 8.5 to 14.4 h, and genital growth is reduced by ∼75%. Transient Shh signalling establishes pattern in the genital tubercle; however, transcriptional levels of G1 cell cycle regulators are reduced. Consequently, G1 length is extended, leading to fewer progenitor cells entering S-phase. Cell cycle genes responded similarly to Shh inactivation in genitalia and limbs, suggesting that Shh may regulate growth by similar mechanisms in different organ systems. The finding that Shh regulates cell number by controlling the length of specific cell cycle phases identifies a novel mechanism by which Shh elaborates pattern during appendage development.
The secreted signalling molecule Sonic hedgehog (Shh) acts to specify
positional identities and to promote cell proliferation and survival in a wide range of organ
systems12345. In the vertebrate limb and brain, for example, Shh has
been proposed to integrate patterning with growth, and in both systems removal of Shh leads to
altered pattern formation because of diminished proliferation of progenitor cells678. Although the Shh pathway can regulate expression of genes that control the
cell cycle, including G1/S cyclins456, the cellular mechanisms by which Shh
influences proliferation are not well understood. Moreover, data from multiple systems suggest
varied and context-specific roles for Shh in control of the cell cycle5.During external genital development, a pair of swellings arises from the anterior margin of
the cloaca and forms the genital tubercle, the embryonic precursor of the penis and clitoris,
which then undergoes a sustained period of proximodistal outgrowth. Growth of the tubercle is
coordinated with three dimensional tissue patterning and urethral tubulogenesis. Transcription
of Shh begins before the initiation of genital budding in a lineage-restricted
compartment of cloacal endoderm that gives rise to the urethral epithelium, and Shh
expression persists through the early stages of sexual differentiation910. In
Shh knocknot mice11, loss of Shh results in complete absence of external
genitalia, and although mutant embryos initiate genital budding, outgrowth arrests before the
formation of a genital tubercle91213. Recent studies demonstrated that
disruption of Shh signalling after initiation of the tubercle results in truncation of the
phallus141516, which raises new questions about the cellular mechanisms
by which Shh integrates organ growth and pattern formation.To address the cellular and molecular mechanisms by which Shh regulates genital outgrowth, we
conducted temporally controlled, tissue-specific deletions of Shh at different stages of
external genital development. We find that very early, transient expression of Shh is
sufficient to specify the normal spatial patterns of gene expression in the genital tubercle;
however, prolonged Shh activity is required for this pattern to be expanded. Disruption of Shh
signalling results in a sustained decrease in the expression of cell cycle regulatory genes
that govern the G1/S transition, as well as a transient downregulation of G2/M promoting
genes. Analysis of cell cycle kinetics after Shh inactivation shows that the duration of the
cell cycle is increased from 8.5 to 14.4 h, and this is due to an increase in the length of
G1. Consequently, fewer progenitor cells enter S-phase, which slows the rate of genital
tubercle growth. We conclude that Shh controls the rate of progenitor cell proliferation, and
thus progenitor pool size, by regulating the speed of the cell cycle in the genital tubercle.
The finding that cell cycle regulatory genes in the limb buds and genital tubercles show
similar responses to Shh inactivation suggests that regulation of cell cycle kinetics by Shh
may be a fundamental aspect of appendage development.
Results
Transient Shh activity specifies pattern but growth is reduced
During external genital development, Shh-expressing cells are confined to the
endoderm and signal to the surrounding mesoderm and ectoderm (Fig.
1a and study by Seifert et al.10). We inactivated
Shh after the initiation of genital budding using a tamoxifen-inducible cre
(Shh) to delete a floxed allele of Shh
(Shh) in Shh
embryos1718. To determine the time required for tamoxifen to activate
cre and induce recombination, we monitored LacZ expression from the Rosa26
reporter (R26R) allele, which is induced in response to cre recombinase19. LacZ was first detectable 6 h after tamoxifen injection, with strong
reporter activity observed in all sites of endogenous Shh expression 9 h after
injection (Fig. 1b). We then identified when Shh signal transduction
was terminated by monitoring expression of Ptch1, a transcriptional readout of the
Shh effector genes, Gli1 and Gli2. Ptch1 transcripts were detected at
low levels in the genitalia 12 h after tamoxifen injection, but were undetectable at 24,
48 and 72 h after injection, demonstrating complete and irreversible inactivation of Shh
signalling by 24 h (Fig. 1c). The extent of genital tubercle
outgrowth in these mutants is correlated with the duration of Shh signalling, with longer
Shh exposures leading to more extensive outgrowth (Fig. 1d).
Figure 1
Temporal inactivation of Shh signalling in the external genitalia.
(a) Lateral view of X-gal-stained Shh;
R26R mouse embryo at E12.5 showing position of LacZ expression in
Shh descendent cells. Image captured using optical
projection tomography. Red box shows schematic of a transverse section through the
external genitalia at the level of the hindlimbs and depicts the position of
Shh-producing cells at the posterior end of the embryo. (b) LacZ
expression (red arrows) in Shh;R26R embryos
collected 6 and 9 h after injection of pregnant dams with tamoxifen. (c)
Comparison of Ptch1 expression in Shh and
Shh embryos 24 and 48 h after tamoxifen injection.
(d) Range of anogenital phenotypes produced by loss of Shh function at
different developmental stages. All mice are males. Left panel shows complete agenesis
of external genitalia and persistence of cloaca in Shh
mutant. Middle panels show anogenital regions of
Shh mice, in which Shh was inactivated at
E11.5 and E13.5 (tamoxifen injection at E10.5 and E12.5, respectively). Right panel
shows normal genitalia of wild-type mouse with normal Shh activity.
To determine whether early removal of Shh affects the establishment of positional
identity in the genital tubercle, we deleted Shh immediately after the emergence of the
genital tubercle and examined the expression patterns of genes that mark specific
positions of the tubercle and are required for external genital development. Wnt5a,
Hoxd13 and Hoxa13 are expressed throughout the tubercle and are required for
outgrowth202122. Bmp4, Bmp7 and Msx2 mark dorsal,
ventral and distal sides of the genital tubercle and regulate several aspects of genital
morphogenesis9122324. Surprisingly, when the Shh pathway was
inactivated as early as E11.5, although the tubercles were reduced in size, normal spatial
expression of Wnt5a, Hoxd13 and Hoxa13 was maintained at E13.5 (Fig. 2a). Bmp4, Bmp7 and Msx2 were also maintained in
appropriate spatial positions 24 and 48 h after the loss of Shh signalling, although the
paired lateral domains of Bmp expression, which correspond to cells of the
preputial glands in wild-type mice, were not detected in Shh conditional mutants (Fig. 2b, Supplementary Fig.
S1). Taken together, these results indicate that the molecular polarity of the
tubercle is maintained in the absence of Shh signalling, demonstrating that only transient
exposure to Shh is required to establish the normal spatial patterns of gene
expression.
Figure 2
Early and transient Shh expression is sufficient for pattern specification in the
genital tubercle.
(a, b) Whole mount in situ hybridizations showing gene expression
patterns in genital tubercles of Shh and control
Shh mice. Genital tubercles are shown in ventral view,
except where indicated. Shh was inactivated by tamoxifen injection at E10.5,
immediately after initiation of tubercle outgrowth, and embryos were collected at E12.5
(Bmp4, and Msx2) or E13.5 (Wnt5a, Hoxd13, Hoxa13, Bmp7). Genital
tubercles are reduced in size but show normal spatial expression patterns except for
absence of Bmp7 expression in preputial glands (red arrow in b). Black
arrows mark regionalized gene expression domains. Enlargement (red box) shows
Bmp7-expressing preputial gland cells in control littermate. (c,
d) qRT–PCR data for genes shown in (a) and (b). Embryos were
injected with tamoxifen at E10.5 and collected at E12.5 (c), and injected at
E11.5 and collected at E13.5 (d). Transcript levels expressed as percentage
relative to control littermates, with n=3 for each data point. Error bars show ±
s.e.m. and asterisks denote significant differences in (c) Msx2
(P=0.009) and (d) Msx2 (P=0.013), Bmp4
(P=0.002) and Bmp7 (P=0.010).
Although spatial domains of gene expression appeared normal in
Shh mutant embryos, patterning defects could
result from diminished levels of transcriptional activity. We therefore deleted Shh
and quantified gene expression levels 48 h after tamoxifen injection. When Shh was
inactivated by an E10.5 injection, only Msx2 showed a significant decrease (Fig. 2c). This was initially surprising, given that Msx2 is
regulated by Bmp4 and Bmp7 in limb buds, however, in the early genital tubercle
Msx2 and Bmp4/7 show little (if any) overlap, suggesting the presence of
other Shh-dependent regulators of Msx2 at this stage. Deletion of Shh by an
E11.5 injection resulted in small but significant decrease in Msx2 as well as
Bmp4 and Bmp7 (Fig. 2b,d and Supplementary Fig. S1). The quantitative
reduction in Bmp4 and Bmp7 levels at E13.5 most likely reflects
downregulation in two areas that normally express Shh; mutants show decreased
signal in and around the urethral plate (Fig. 2b and Supplementary Fig. S1), and absence of signal
where the preputial glands normally form (Fig. 2b). Loss of gene
expression in the preputial glands correlated with ventral hypoplasia of the prepuce,
which normally surrounds the tubercle, suggesting that preputial development might be
partly governed by Shh. Collectively, the spatial expression patterns observed by in
situ hybridization and the quantitative levels of expression detected by
quantitative reverse transcription–polymerase chain reaction (qRT–PCR) suggest that
transient Shh activity at the initiation of outgrowth is sufficient for the normal pattern
specification in the genital tubercle, but that sustained Shh activity is required for
transcription to be maintained at appropriate levels.
Shh controls cell number and expression of cell cycle genes
Once a molecular pre-pattern has been established in a developing organ, elaboration of
the pattern requires extensive growth. To dissect the role of Shh in the expansion of
genital tubercle progenitor cells, we quantified genital tubercle volume and total cell
number in Shh mutant and control embryos (Fig. 3a–f). Twenty-four hours after inactivation of Shh signalling,
genital tubercle volume and total cell number were decreased by ∼75%
(t(4)=3.64, P=0.01 and t(4)=2.92,
P=0.02 respectively; Fig. 3b–e). Neither cell death nor cell
density differed significantly (for density, t(4)=1.33, P=0.12;
Fig. 3f and Supplementary
Fig. S2), indicating that the reduction in progenitor cell number was not due to
dying cells. To test the hypothesis that the growth deficiency reflected a disruption of
cell proliferation, we first searched for Shh target genes that could mediate its
mitogenic effects. The transcription factors Foxf1 and Foxf2, which have
been implicated in Shh-mediated control of the cell cycle2526, were
downregulated within 24 h of Shh inactivation (Supplementary Fig. S3). We next used the quantitative RT2–PCR
Profiler Array to monitor the response of 84 genes involved in cell cycle regulation, and
compared Shh mutant and control genitalia at
different time points after inactivation of Shh (Fig. 4a,b).
Examination of cell cycle genes 24 h after tamoxifen injection revealed significant
reductions in the levels of cell cycle control genes that control both the G1/S transition
(Cyclin E1, Dp1) and G2/M-phase progression (Cyclin B1, Cdc25a;
Fig. 4a,b). Cyclin E1, Dp1 and the Dp binding
partner E2f1 remained significantly reduced for at least 24 h after Shh
inactivation, suggesting a sustained disruption in G1 progression (Fig.
4a,b). Myc levels also decreased (see below and Fig.
4c) but three Cdk inhibitors, Cdkn1a, Cdkn1b and Cdkn2a, did not
change significantly (P=0.64, 0.959 and 0.492, respectively). We also observed a
significant decrease in the S-phase promoting gene Cyclin A1 and a small but
significant decrease in the helicase components Mcm2 and Mcm3, which are
involved in DNA replication (Fig. 4a,b). These results show that
loss of Shh causes a transient downregulation of G2/M promoting genes and a sustained
decrease in the expression of genes that govern the G1/S transition. Our discovery that
Shh regulates expression of Myc, Rb1, Dp1 and E2f1 suggests a
novel mechanism by which Shh can exercise fine-scale control of cyclin levels through
control of cyclin modifiers.
Figure 3
Stereological estimates reveal decreased cell number in Shh-depleted
genitalia.
(a–c) Genital tubercles of Shh and
control Shh embryos are shown at E12.5. Pregnant females
were injected with tamoxifen at E10.5 and with BrdU 44 h later. (a) Lateral view
of E12.5 Shh;R26R embryo stained with X-Gal to
show Shh-expressing cells10. Red box marks region of genital
tubercle (gt) and underlying cloacal endoderm shown in (b) and (c).
(b, c) Control Shh (b) and
Shh (c) embryos at ×10 magnification
showing BrdU-labelled cells (red). (d–f) Estimates of volume (d)
total mesenchymal cell number (e) and cell density (f) in
Shh (white bars; n=3) and control
Shh (black bars; n=3) embryos. Data represented
as means with ± s.e.m. *P<0.05.
Figure 4
Shh inactivation alters cell cycle gene expression in genital tubercles and limb
buds.
(a, b) Quantitative comparison of transcript levels in
Shh and Shh
embryos assayed at three time points (indicated in key) using the RT2-Profiler PCR Array (SABiosciences). Tamoxifen injections were administered at E10.5
and E11.5. Changes in transcript level are expressed as percent change relative to
control embryos for G/S-phase cell cycle genes (a) and S- and G2/M-phase genes
(b). Error bars show ± s.e.m., n = 3 and asterisks denote significant
differences for E11.5 injection/E12.5 collection (Cyclin E1, P=0.030; Dp1,
P=0.055; Cyclin B1, P=0.019; Cdc25a, P=0.034; Mcm3, P=0.031),
E10.5 injection/E12.5 collection (Cyclin A1, P=0.011; E2f1, P=0.013),
E11.5 injection/E13.5 collection (Cyclin A1, P=0.0004; Cyclin E1, P=0.027;
Dp1, P=0.033; E2f1, P=0.010; Mcm2, P=0.052). (c) Graph
shows comparison of transcript levels in limb buds (grey bars) and genital tubercles
(black bars) of Shh relative to
Shh embryos. Tamoxifen injections were administered
at E10.5 and embryos were collected for qRT–PCR at E12.5. Changes in transcript level
are expressed as percent change relative to control embryos. Error bars show ± s.e.m.,
n = 3 and asterisks denote significant differences in E2f1 (GT,
P=0.010; limb, P=0.008), Dp1 (GT, P=0.012; limb,
P=0.026), Myc (GT, P=0.034; limb, P=0.039) and Rb1
(GT, P=0.040; limb, P=0.040).
Cell cycle gene regulation is conserved in limbs and genitalia
Cyclin D1, which has been reported to be a target of Shh signalling in other
contexts62728, showed no significant differences between
Shh mutant and control genitalia by two
independent quantitative analyses (qRT–PCR, P=0.743;. RT2 Profiler
Array, P=0.251). This led us to investigate whether the Shh pathway acts on
different cell cycle regulators in different tissues. We compared E12.5 limb buds and
genital tubercles in which Shh had been inactivated at E11.5 (by tamoxifen injection 24 h
earlier), when Shh is expressed in both structures. qRT–PCR analysis showed that, as in
the genital tubercle, mutant and control limb buds at E12.5 showed no significant
difference in Cyclin D1 expression levels (P=0.788). However, the limb buds
and genital tubercles undergo significant decreases in E2f1, Dp1 and Myc
expression, and significant increases in expression of Rb1, a negative regulator of
S-phase entry (Fig. 4c). Given that Rb1 binds and inactivates E2f1
(study by Rubin et al.29), the consequence of decreased levels of
E2f1 and increased levels of Rb1 would be an even further reduction of
E2f1 activity during the G1–S transition, both in the genital tubercle and limb bud. These
findings show that Shh can control the same cell cycle regulators in different tissues,
suggesting that conserved mechanisms may mediate the ability of Shh to regulate outgrowth
of different types of appendages.
Cell cycle kinetics are disrupted by Shh inactivation
The finding that Shh controls quantitative levels of expression of multiple cell cycle
regulators raised the possibility that the growth deficiency of
Shh genitalia could be caused by disruption of
the cell cycle. Given that genital outgrowth slows but does not arrest after Shh
inactivation, we tested the hypothesis that Shh may regulate the rate of genital outgrowth
by regulating the kinetics of the cell cycle8. Cell proliferation kinetics
were examined quantitatively by calculating the proportion of cells in different phases of
the cell cycle in the genitalia of Shh embryos. To
label cells in S-phase, bromodeoxyuridine (BrdU) was injected 20 h after inactivation of
the Shh pathway and embryos were allowed to develop in utero for 4 h to allow
sufficient time for BrdU-labelled cells to transition from S-phase to G2/M-phase. Embryos
were then harvested and labelled with antibodies against BrdU and phosphorylated Histone
H3 (PHH3), a marker for cells in G2/M-phase30. We calculated the proportion
of mesenchymal cells that were labelled with BrdU alone (S-phase), PHH3 alone
(G2/M-phase), double labelled with BrdU and PHH3 (S-phase cells that had moved into
G2/M-phase within 4 h) or were unlabelled (G0/G1) (Fig. 5; see
Methods section). An analysis of variance revealed
differences in the proportion of cells in S-phase, G2/M-phase and G0/G1 in
Shh mutant versus
Shh littermates that approached significance
(F(2,8)=4; P=0.06). Planned comparisons of the proportion of cells in
S-phase, G2/M-phase and G0/G1 phase indicated that
Shh mutant animals (n=3) had an 8% decrease
in S-phase cells (P=0.03) and a 7% increase in G0/G1-phase cells (P=0.05)
relative to Shh littermates (n=3; Fig. 5a). The observation that Shh mutants
exhibit a reduction in the number of cells in S-phase and a concomitant increase in the
proportion of cells in G0/G1 is consistent with our finding that genes regulating the G1/S
transition are reduced, and suggests that progression through G1 or the G1/S checkpoint is
disrupted when Shh is removed.
Figure 5
Shh controls growth of the genital tubercle by regulating cell cycle
kinetics.
(a) Proportion of cells in each phase of the cell cycle. Labelling scheme groups
G2 and M. Error bars show s.e.m., n = 3, * P<0.05. (b)
Estimated cell cycle times for Shh (mutant) and
Shh (control) embryos. Means are shown for mutant and
control embryos and s.e. of the mean is provided for Tc. (c) Total
cell number calculated for each phase of the cell cycle at E12.5. Error bars show
s.e.m., n = 3. (d) Summary of cell labelling scheme used to determine
lengths of S-phase (Ts) and total cell cycle (Tc). The red arcs
refer to cell population labelled with BrdU, the blue arc refers to cell population
labelled with phosphohistone-H3, and green arc refers to cell population labelled with
only DAPI (arc lengths not to scale). (e) Sagittal section through genital
tubercle of Shh embryo at E12.5 shown at ×10
magnification. White box depicts area of counting frame used for cell counts.
(f–i) High magnification (×145), single channel (f–h) and
merged (i) exposures of boxed area in (e) showing cells labelled with DAPI
(white, panel f) BrdU (red, panel g), phosphohistone-H3 (green, panel
h). Yellow arrowheads mark examples of cells positive for both PHH3 and BrdU,
and the white arrowhead marks a cell positive for BrdU but negative for PHH3.
A longer G1 phase underlies the growth defect in Shh mutants
How could these relatively small proportional shifts in cell cycle phase lead to the
large growth differences that result from deletion of Shh? If Shh is involved in
regulating G1/S and G2/M transitions, then one possibility is that loss of Shh signalling
induces cells to arrest at specific cycle checkpoints, thereby arresting proliferation or
inducing apoptosis; however, such changes did not occur after deletion of Shh (Fig. 1d and Supplementary Fig.
S2). Alternatively, inactivation of Shh could decrease the rate of progression
through G1, which would be reflected by increased cycle length. To calculate cell cycle
kinetics of progenitor cells in the developing genital tubercle mesenchyme, we applied the
principles developed by Nowakowski et al.31 for quantification of
cell cycle length. The relative lengths of S-phase (TS) and the entire cell
cycle (Tc) were determined for both Shh
(n=3) and wild-type littermates (n=3) by measuring the proportions of
cells in S-phase (BrdU/4,6-diamidino-2-phenylindole (DAPI) positive), S-phase cells that
have cycled through G2/M (BrdU/PHH3/DAPI positive) and unlabelled cells (DAPI positive;
see formulas in Fig. 5d and labelled cells in Fig.
5e–i). Inactivation of Shh signalling at E11.5 resulted in lengthening of the
entire cell cycle (Tc) from 8.5 to 14.4 h (t(4)=2.83;
P=0.024) (Fig. 5b). BrdU analysis revealed a greater
proportion of unlabelled cells in Shh mutants
(t(4)=1.62; P=0.09), suggesting that this lengthening is not a
result of altered S-phase duration but more likely reflects a delay in G1 or the G1/S
checkpoint (Fig. 5b). Such a marked increase in cell cycle duration
would be expected to reduce the total cell number, which may account for the ∼75%
reduction of tubercle volume in Shh mutants. Indeed,
when the proportion of cells in each phase of the cell cycle is weighed against total cell
number, the data show that the loss of Shh signalling decreases the cycling cell
population by ∼73% (Fig. 5c). Thus, loss of Shh activity lengthens
the time that cells spend in G1/G0, thereby reducing the number of cells in S-phase,
which, in turn, feeds fewer cells into G2/M-phase and, ultimately, back into the cell
cycle (Fig. 6). Taken together, these data indicate that Shh
controls the rate of progenitor cell proliferation, and thus progenitor pool size, by
regulating the speed of the cell cycle. This highlights a novel mechanism for Shh-mediated
control of organ growth.
Figure 6
A model for Shh-mediated integration of growth and patterning.
Shh activity in wild-type (WT) and Shh (mutant)
genital tubercles is shown in top panel, and is based on analysis of Ptch1
expression (see Fig. 1c). During outgrowth of the genital
tubercle, cell populations (red, tan, black coloured circles) defined by regionalized
gene expression are exposed to secreted Shh (blue shaded areas). In wild-type genitalia,
these cells divide approximately every 8.5 h and, as these progenitor pools double in
number, this expands gene expression patterns. Following loss of Shh activity in mutant
genitalia, cells continue to divide but cell cycle length increases to 14.4 h. This
leads to a reduction in both the doubling rate of progenitor pools and the overall size
of the genital tubercle. The general molecular pattern of the mutant tubercle is
retained. Large red circles above and below tubercles represent the doubling time of all
cells in the genital tubercle. Tc, total cell cycle time.
Discussion
These studies demonstrate that transcriptional levels of genes that control the G1/S
transition are quantitatively regulated by the Shh pathway during external genital and limb
outgrowth. This extends previous in vitro studies that showed that Shh and its
downstream effectors can interact with specific cell cycle proteins to drive both growth
phases of the cell cycle456832. Our finding that Shh activity
determines the level of Dp1 and its E2f binding partners, which are activators
of Cyclin E and A1, may account for the reduced Cyclin levels in Shh mutant
embryos. Cyclin E and A1 expression may be further refined by Shh through the
increased negative regulation of Rb1, which limits E2f1 activity. Although hedgehog
gain-of-function studies have suggested a role for Cyclin D1 in Shh-mediated control
of cell proliferation, our quantitative analysis showed minimal changes in Cyclin D1
levels in mouse limbs and genitalia after the loss of Shh, which is consistent with results
from the chick limb6. Taken together, these data reveal new molecular
mechanisms for Shh-mediated regulation of cell cycle length, specifically the duration of G1
and the G1/S transition, and highlight how subtle changes in the kinetics of the cell cycle
are amplified over developmental time to alter morphological pattern.On the basis of these results, we suggest that after the early pattern is specified in the
genital tubercle, Shh promotes its elaboration and growth by regulating the length of the
cell cycle (Fig. 6). The control mechanism identified here may also
operate in other signalling pathways and has implications for other developing organs. In
the limb, for example, two recent studies reported that Shh specifies digit identity at
early stages and that sustained expression is required for proliferation of progenitor cells
and normal elaboration of skeletal pattern67. Both studies reported changes
in the proportion of cells in different phases of the cell cycle, although how such changes
can lead to a reduction of organ growth is not well understood at the cellular level. In
light of our finding that Shh signalling determines the length of specific cell cycle
phases, and that Shh regulates the same cell cycle control genes in the genital tubercle and
limb bud, one possibility is that the loss of digits and the proximodistal truncations
associated with reduced Shh activity in the limb may be caused by temporal changes in cell
cycle kinetics, similar to those observed in the genitalia.Factors that alter cell cycle rates during the development can influence the morphology and
size of an organ, and this may reflect the extent to which the early pattern has been
amplified during growth33. Shh-mediated modulation of cell cycle duration may
also underlie heterochronic changes during morphological evolution. For example, temporal
truncation of Shh expression in the limb bud is associated with decreased
proliferation and reduction of digit number in skinks34. Our results predict
that such a reduction of Shh activity would lengthen cell cycle duration and thereby
decrease the progenitor cell population in the limb. Similarly, the ability of hedgehog to
alter cell cycle length may influence the rate of tumour growth in hedgehog pathway-mediated
cancers35. Thus, these findings highlight the potential for modulators of
cell cycle length to result in phenotypic changes in development, disease and evolution.
Methods
Animals
The Shh,Shh,
Shh and R26R alleles have been described
elsewhere171819. Tamoxifen (3 mg dissolved in corn oil) was
administered to pregnant females at E10.5, E11.5 and E12.5 to induce cre-mediated deletion
of Shh. BrdU (100 mg per kg) was injected 44 h after
tamoxifen to label cells in the S-phase of mitosis, and pups were collected 4 h later for
analysis of cell cycle kinetics. All animal experiments were performed in accordance with
institutional guidelines.
Immunohistochemistry
Tissue was incubated in rat anti-BrdU (1:500;
Accurate) and mouse anti-phosphorylated Histone-H3 (1:500; Upstate)
overnight at 4 °C and then in the minimally cross-reactive secondary donkey anti-ratCy3 and donkey anti-mouseCy5 (1:500, Jackson Immunoresearch) antibodies overnight at 4 °C. The tissue was
washed repeatedly between steps with tris-buffered saline. Live embryos were immersed in
Lysotracker Red (1:5,000; Molecular Probes) at 37 °C for 30 min to label regions of cell death, then
washed in phosphate-buffered saline and dehydrated in methanol for imaging.
In situ hybridization
Whole mount in situ hybridization was conducted according to published
methods9 using digoxigenin-lablelled riboprobes for Shh (kindly
provided by A. McMahon), Wnt5a (A. McMahon), Ptch1 (M. Scott) Hoxd13
(D. Duboule), Hoxa13 (S. Stadler), Bmp4 (B. Hogan), Bmp7 (B. Hogan),
Msx2 (R. Hill), FoxF1 (P. Carlsson) and FoxF2 (P. Carlsson).
Quantitative RT–PCR
Shh and control
(Shh) mice were collected from the same litters of
tamoxifen-treated mothers. Genital tubercles were dissected from stage-matched embryos and
were pooled according to genotype for each litter collected. RNA was extracted using
Trizol. After treatment with RNase-free DNase I
(Ambion), three pooled samples for each genotype were
purified using the RNeasy Mini kit (Qiagen). RNA quantity and purity were determined using a NanoDrop
ND-1000, and RNA integrity was assessed by determining the RNA integrity number and
28S/18S ratio using a Bioanalyzer 2100 (Agilent Technologies). A quantity of 500 ng of high-quality RNA
(260/280 ratios slightly higher than 2.0 and 260/230 ratios higher than 1.7,
RIN>8.0) for each pooled sample was converted into cDNA using the RT2 First Strand cDNA Kit (SABiosciences). All qPCR reactions use the RT2 SYBR Green qPCR Master Mix (SABiosciences). Cell cycle gene expression was determined using Cell Cycle PCR Array (PAMM-020, SABiosciences) and the My iQ5 system
(Bio-Rad) according to the manufacturer's protocol. All
significant changes in gene expression levels are reported in the article; the complete
list of genes assayed on the array can be found at the manufacturer's website
(http://www.sabioscience.com/rt_pcr_product/HTML/PAMM-020A.html). For
patterning genes and additional cell cycle genes, expression was detected using the My iQ5 QPCR system (Bio-Rad) with Actb and Gapdh36 as controls. Primers not
previously published were designed using Beacon Designer Software (except for Actb, which
was purchased from http://www.realtimeprimers.com). The qRT–PCR primers
designed for this study are listed in Table 1.
Table 1
qRT–PCR primer sequences.
Primer
Sequence
Sequence source
Msx2 Fwd
CGTGTTGGGCAGATGGAGAAG
GenBank accession # 013601
Msx2 Rev
AGAGATGGACAGGAAGGTGAGAC
Bmp4 Fwd
GAACAGGGCTTCCACCGTATAAAC
GenBank accession # 007554
Bmp4 Rev
TGTCCAGTAGTCGTGTGATGAGG
Bmp7 Fwd
TCTTCCTGAGACCCTGACCTTTG
GenBank accession # 007557
Bmp7 Rev
TGGGCAGTGAGAGACTTAGATGG
Ccnd1 Fwd
GCGTACCCTGACACCAATCT
GenBank accession # 007631
Ccnd1 Rev
CTCTTCGCACTTCTGCTCCT
Rb1 Fwd
GCAAGTTGATTGACTGTCCACATTC
GenBank accession # 009029
Rb1 Rev
AAACAAACACACGGCACATTAGATTC
E2f1 Fwd
GGAAAGGGAGAGGGAGACAGAC
GenBank accession # 007891
E2f1 Rev
AGCCATAGGAAGGACGCATACC
Tfdp1 Fwd
TGAGAACGACGAGGAGGATTGATTAC
GenBank accession # 009361
Tfdp1 Rev
CACGCTGGCTTCACAACACATC
Actb Fwd
AAGAGCTATGAGCTGCCTGA
http://www.Realtimeprimers.com
Actb Rev
TACGGATGTCAACGTCACAC
Stereological estimates of total cell numbers
Total (DAPI-labelled), S-phase (BrdU-labelled), S- and G2/M-transition phase (BrdU/PHH3)
and G2/M-phase (PHH3) cells were estimated stereologically using the optical fractionator
method by counting target cells on every 12th midsagittal section (∼6 sections through the
entire mediolateral axis of mesenchyme in both Shh
mutants and control littermates), following published methods for counting cells through
irregularly shaped structures, such as brain regions or kidneys3738.
Briefly, cells of interest were counted on images acquired using a ×10 objective, N.A. 0.3
on an AxioObserver Microscope and AxioVision
Software (version 4.1; Zeiss). Section thickness
was confirmed to be ∼12 μm by focusing through the sample. Cells that fell within the
45×45 μm counting frame (in a sampling grid of 235×235 μm) were used in the analyses. To
estimate total mesenchymal volume, the area of mesenchyme on each section was traced and
quantified using AxioVision software and the total volume of the structure was estimated
using Cavalieri's principle37. Densities were determined by dividing the
number of cells in the region of interest by the area in which the cells were counted
(that is, 45×45 μm). Proportions of cells were calculated by counting total cells
(DAPI-labelled) and S-phase cells (BrdU-labelled) in five separate counting frames per
section, and G2/M-transition phase (BrdU/PHH3) and G2/M-phase (PHH3) cells were counted on
the entire section. This was performed to avoid subsampling errors due to the low number
of PHH3-positive cells per section.
Cell cycle kinetics
Females were injected with tamoxifen and BrdU as described in the text. S-phase and total
cell cycle length were calculated according to equations in Figure
5. BrdU labels cells approximately 30 min after injection3940 and
is metabolized in approximately 2 h,3139. Given that S-phase in both
mouse and chick mesenchyme (paraxial and lateral plate) in vivo is at least 3
h4142, a 4-h interval between injection and collection was chosen to
allow BrdU-labelled mesenchymal cells to transition from S-phase to G2/M-phase. Although
this may result in slight under-representation of cells that transitioned from G1- to
S-phase after BrdU metabolism, and cells in late S-phase would be BrdU positive in early
G2, on the basis of the relative nature of the proportion calculations, the percentages
reported for each phase are accurate using this labelling scheme.
Statistical analysis
All group differences in our dependent variables were revealed using Student's
t-tests (one dependent variable between groups) or analysis of variances (more than
one dependent variable between groups) and explored using Newman–Kewls post hoc
tests. α-Levels were set at 0.05.
Volumetric measures
Tubercle mesenchyme volume differences between Shh
and wild-type littermates were determined using Cavalieri's principle37.
Total cell numbers were estimated for G1/G0 (DAPI positive), S-Phase (BrdU positive) and
G2/M-phase (BrdU/PHH3 positive cells) using the optical fractionator principle on every
12th section through the structure (∼6 sections per animal)37. Proportions
and densities of cells were also calculated in different phases of the cell cycle.
Author contributions
A.W.S. and M.J.C. designed the research, A.W.S. conducted transgenic mouse work and
performed in situ hybridizations and cell cycle experiments, Z.Z. designed and
performed qRT–PCR analysis and analysed the SABioscience Profiler Arrays with A.W.S.. B.K.O.
and A.W.S. designed and analysed the cell cycle experiments and performed the statistical
analysis. A.W.S. and M.J.C. wrote the article. All authors discussed the results and
commented on the article.
Additional information
How to cite this article: Seifert, A.W. et al. Sonic hedgehog controls
growth of external genitalia by regulating cell cycle kinetics. Nat. Commun. 1:23
doi: 10.1038/1020 (2010).
Authors: M J Hendzel; Y Wei; M A Mancini; A Van Hooser; T Ranalli; B R Brinkley; D P Bazett-Jones; C D Allis Journal: Chromosoma Date: 1997-11 Impact factor: 4.316
Authors: Blair B Madison; Lindsay B McKenna; Diane Dolson; Douglas J Epstein; Klaus H Kaestner Journal: J Biol Chem Date: 2008-12-02 Impact factor: 5.157
Authors: Robert L Yauch; Stephen E Gould; Suzie J Scales; Tracy Tang; Hua Tian; Christina P Ahn; Derek Marshall; Ling Fu; Thomas Januario; Dara Kallop; Michelle Nannini-Pepe; Karen Kotkow; James C Marsters; Lee L Rubin; Frederic J de Sauvage Journal: Nature Date: 2008-08-27 Impact factor: 49.962
Authors: Saunders T Ching; Carlos R Infante; Wen Du; Amnon Sharir; Sungdae Park; Douglas B Menke; Ophir D Klein Journal: Hum Mol Genet Date: 2018-01-01 Impact factor: 6.150
Authors: Carlos R Infante; Alexandra G Mihala; Sungdae Park; Jialiang S Wang; Kenji K Johnson; James D Lauderdale; Douglas B Menke Journal: Dev Cell Date: 2015-10-01 Impact factor: 12.270
Authors: Emmanuel S Antonarakis; Elisabeth I Heath; David C Smith; Dana Rathkopf; Amanda L Blackford; Daniel C Danila; Serina King; Anja Frost; A Seun Ajiboye; Ming Zhao; Janet Mendonca; Sushant K Kachhap; Michelle A Rudek; Michael A Carducci Journal: Oncologist Date: 2013-01-22
Authors: H Scott Stadler; Craig A Peters; Renea M Sturm; Linda A Baker; Carolyn J M Best; Victoria Y Bird; Frank Geller; Deborah K Hoshizaki; Thomas B Knudsen; Jenna M Norton; Rodrigo L P Romao; Martin J Cohn Journal: J Pediatr Urol Date: 2020-09-16 Impact factor: 1.830